Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

66
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
66

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcutaneous CO<sub>2</sub> Therapy Improves Tissue Oxygenation, Ulcer Healing and Pain in Recurrent Hard-to-Heal Diabetic Foot Ulcers: A Randomized Controlled Trial.

The international journal of lower extremity wounds·2026
Same author

Five-Year Outcomes of Paclitaxel-Coated Balloons in Patients with Diabetes from the BIOLUX P-III Single-Arm Study.

Vascular health and risk management·2026
Same author

Less Metal, More Patency: The DASBAD Trial Delivers Evidence for Vessel Preparation in Chronic Limb Threatening Ischaemia.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2026
Same author

Adequacy and utilization of greater saphenous vein in patients undergoing preoperative vein mapping for chronic limb-threatening ischemia.

Journal of vascular surgery·2026
Same author

An international, multispecialty consensus document on the optimal management of patients with internal carotid artery occlusion.

Journal of vascular surgery·2026
Same author

Contemporary systematic review and meta-analysis of outcomes associated with femoropopliteal above-the-knee nonautologous surgical bypass.

Journal of vascular surgery·2026

Related Experiment Video

Updated: Oct 19, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.5K

Progress on developing an effective below-the-knee drug-coated balloon.

Rym El Khoury1, Marianne Brodmann2, Peter A Schneider1

  • 1Division of Vascular and Endovascular Surgery, University of California, San Francisco, CA 94143, USA.

Reviews in Cardiovascular Medicine
|September 26, 2021
PubMed
Summary
This summary is machine-generated.

Drug-coated balloons (DCBs) face challenges in treating infrapopliteal atherosclerotic disease due to restenosis and recoil. This review explores DCB evolution, clinical results, and future technologies for below-the-knee lesions.

Keywords:
Below-the-kneeDevice designDrug-coated balloonInfrapoplitealPeripheral arterial disease

More Related Videos

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application
06:53

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application

Published on: July 9, 2020

5.2K
Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins
05:44

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

Published on: May 24, 2024

793

Related Experiment Videos

Last Updated: Oct 19, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.5K
A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application
06:53

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application

Published on: July 9, 2020

5.2K
Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins
05:44

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

Published on: May 24, 2024

793

Area of Science:

  • Vascular medicine and interventional cardiology
  • Biomaterials and drug delivery systems

Background:

  • Infrapopliteal atherosclerotic disease presents significant challenges for endovascular treatment.
  • Conventional angioplasty often results in early restenosis and recoil in complex, calcified, below-the-knee lesions.
  • Drug-eluting stents successful in coronary arteries have shown limited efficacy in tibial arteries.

Purpose of the Study:

  • To review the evolution and challenges of drug-coated balloon (DCB) technology for infrapopliteal arteries.
  • To present clinical outcomes of currently available tibial DCBs.
  • To introduce emerging advancements in DCB technology.

Main Methods:

  • Review of existing literature on infrapopliteal angioplasty and DCB technology.
  • Analysis of clinical trial data for paclitaxel-coated balloons and other DCBs.
  • Discussion of the scientific basis and future directions of DCB development.

Main Results:

  • Conventional angioplasty has limitations in treating complex infrapopliteal lesions.
  • Initial promise of paclitaxel-coated balloons has not been consistently met in large trials.
  • Controversy exists regarding paclitaxel-associated mortality.

Conclusions:

  • Drug-coated balloons represent an evolving therapeutic option for infrapopliteal atherosclerotic disease.
  • Further research and technological innovation are needed to overcome current limitations.
  • New horizons in DCB technology may offer improved outcomes for below-the-knee interventions.